ResearcherAffiliated Hospital of Qingdao UniversityActive in the last 2 years

Bin Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-1295-6353; OpenAlex author ID A5125667164. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

[Comparison of clinical outcomes between neoadjuvant therapy and upfront surgery in resectable pancreatic cancer: a meta-analysis]. Last author DOI 10.3760/cma.j.cn112139-20250709-00343 ↗
Circ_0005397 inhibits ferroptosis of pancreatic cancer cells by up-regulating PCBP2 through KAT6A/H3K9Ac. Last author DOI 10.1096/fj.202401151r ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

H L Liu · 1 shared paper, 2026 · strength 0.33
- Paper [Comparison of clinical outcomes between neoadjuvant therapy and upfront surgery in resectable pancreatic cancer: a met… DOI 10.3760/cma.j.cn112139-20250709-00343 ↗
T. T. Qu · 1 shared paper, 2024 · strength 0.20
- Paper Circ_0005397 inhibits ferroptosis of pancreatic cancer cells by up-regulating PCBP2 through KAT6A/H3K9Ac. DOI 10.1096/fj.202401151r ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.